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INTRODUCTION AND AIMS POPULATION AND METHODS
Peritoneal dialysis (PD) and hemodialysis (HD) are complementary
modalities for renal replacement therapy. Changes from PD to HD are
usual and seen as an integrative care approach for end stage renal
patients1.
However, transferences from HD to PD are less frequent and less
characterized.
The aim of this study was to evaluate the outcome of patients
This was a single center retrospective study that included all incident
PD patients from May 2005 to November 2011.
We excluded from the study HIV infected patients and allograft failure
patients.
Clinical data: age, gender, race, co-morbilities
(HCV, diabetes), peritonites, hospitalizations.
L b t i l d t KT /V PET ti i l (C Cl) lb i Ctransferred from HD to PD, and compare them to those that started
dialysis with PD.
a ora or a a a: w , , crea n ne c earence r , a um n, -
reactive protein (CRP).
RESULTS
Clinical characteristics of the population
16 614
2 HIV+
Group A Group B p
Female gender 57.1% (8) 40.5% (15) >0.05
Mean age 54 5±17 2 50 2±14 >0 05
37
Reason for transferrence





. . . .
White race 92.8% (13) 94.6% (35) >0.05
HCV + 14.3% (2) 0% 0.02
Arterial hypertension 78.6% (11) 64.9% (24) >0.05
Diabetes 28.6% (4) 29.7% (11) >0.05
Nephrology appointment
Group B
Patientss transferred from HD were older, were mainly females, and had higher prevalence
Patient preference 1
Mean time in HD (Months) 43.5±27.3
Grupo B Grupo A p
Peritonites
Infections/year 1.3 0.8 <0.001
Mean time for 1st infection 6 9±5 10 8±12 4 0 01
Group A Group B p
KTw/V 1.9±0.6 1.9±0.6 >0.05
for hepatitis C virus infection. Presence of arterial hypertension was also more frequent.
Laboratorial data after the first month in PD
Clinical follow up (complications) of the population
  . . . .
Pseudomonas infection 2 1 >0.05
Hospitalizations
Number/year 4.1±2.7 1±0.9 0.001
Length (days) 14.8±6.9 5.5±6.2 <0.001
CrCl (ml/min) 1.8±3.9 10.3±2.9 <0.001
Albumin (g/dl) 3.4±0.5 3.6±0.5 >0.05
CRP (mg/dl) 2±2.6 1±1.6 0.02
Malnutrition 57.1% 13.5% 0.02
Patients transferred from HD had lower residual renal 
f ti Alb i l d CRP d l t iti
Patients transferred from HD had superior peritonites rate, as well need of
hospitalizations, and hospitalization lengt .
Group A Group B p
PD descontinuation 85.7% (12) 1 (2.7%) 0.01
Death 6 (42.9%) 1 (2.7%) <0.001
unc on. um n was ower, an  an ma nu r on
higher comparing with naive patients
Clinical follow up of the population Mortality
r p
In univariate analysis, mortality was associated with history of
hemodialysis, time on hemodialysis, malnutrition, CRP and
hospitalizations. Residual renal function was also a predictor of mortality.
Renal transplant 4 (28.6%) 8 (21.6%) >0.05
HD transferrence 2 (14%) 16 (43.2%) 0.03
Mean time in PD 26.1±17.7 22.3±20 >0.05
Patients transferred from HD had high rate for PD descontinuation, mainly by
death, but also because of renal transplantation, or even HD re-transferrence.
HD first 0.5 <0.001
Time in HD 0.6 <0.001
Residual renal function -0.6 <0.001
Malnutrition 0.7 <0.001
CRP values 0.4 0.04
Hospitalization length 0.5 0.001
CONCLUSIONS
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PD is suitable for patients transferred from HD, extending life time, and allowing for kidney transplantation in some.
Mortality rate was higher in this group of patients, being residual renal function a good predictor of survival.
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